Table: begin end state 1 38 cytoplasmic 39 60 transmembrane 61 70 non-cytoplasmic 71 89 transmembrane 90 109 cytoplasmic 110 129 transmembrane 130 151 non-cytoplasmic 152 171 transmembrane 172 177 cytoplasmic 178 196 transmembrane 197 210 non-cytoplasmic 211 247 transmembrane 248 255 cytoplasmic 256 258 non-cytoplasmic 259 278 transmembrane 279 297 non-cytoplasmic 298 301 cytoplasmic 302 317 transmembrane 318 342 cytoplasmic 343 367 transmembrane 368 378 non-cytoplasmic 379 400 transmembrane 401 436 cytoplasmic 437 458 transmembrane 459 463 non-cytoplasmic 464 483 transmembrane 484 494 cytoplasmic 495 517 transmembrane 518 536 non-cytoplasmic 537 564 transmembrane 565 574 cytoplasmic 575 597 transmembrane 598 617 non-cytoplasmic 618 645 transmembrane 646 651 cytoplasmic
Input: >WP_011382867.1 MSGGAQHDAILATDTLPAVTVRNPVIAVFEAVMEGAFKLSALALLAAAGVLTFGVVMGHL TGRGLLWQDEVTVFLISGAVFLSAASVQARRGHVAIDFLDHAFPYAKDLRHAVVEAGILA FCLIFAWKSGMLLAEAVHEGQTSQSAWGPPLWIPYSVLTLGMALLALQVMLQVGRRSLWL LAVVVAGVAAFLLATPPVKPLVSGLPHWLTGIAYATVTLLVMFSGMPIAFALGVVALIFM LLFMPAASVDTIAQNFYEELANVIILAIPLFILKGATIGRSNAGKDLYSALHAWLHRIPG GLGVANTIACGLFAAMAGSSPATCSAIGSAGIPEMRARGYSPGFAAGIIAAGGTLGILLP PSVTMLLYAVAAEVSLGRLFLAGIGPGLLLITLFAGYSVLRYRHEYRRAERAAASHGTHS ALLADEHYTTRQKIRMVVWVAPFVTILAGVMVVLYAGWATPSETAGVGAVLALLVIGLMY GIWRPRLLMPILTGTLRESTMLLMIIGMSLLYAYVMSHLRISQAAADWIIGLALSKWFLL AAILLFTVVLGFFLPPVSIILMTAPIILPPLKAAGFDLIWFGVVMTVVMEMGLIHPPVGL NIFVIKNIAPDIPLRDIIWGTLPFVLIMMVAVVACCLIPGIATWLPGAVMG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server